基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the complete record of transactions filed by Kariuki Enoch, 董事. Insider active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 4 reports have been logged. Activity tracked since 8 June 2022. The latest transaction was filed on 17 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Enoch Kariuki is a Board Member at Zentalis Pharmaceuticals, Inc. He is involved in overseeing operations and the strategic direction of the company. With his industry experience, he makes significant contributions to decisions influencing the future of Zentalis. His role is crucial in ensuring the organization's growth and sustainability.